Table 2.
Broad Grouping | ICCC | Gender (95% CI) | Race (95% CI) | Era of diagnosis (95% CI) | Total (95% CI) | >1 month–2 years | |||
---|---|---|---|---|---|---|---|---|---|
Male | Female | White | Non ‐ White | 1973–1990 | 1991–2007 | ||||
Leukemias | I Leukemias, myeloproliferative & myelodysplastic diseases: | 41.6 (25.9–57.3) | 37.7 (22.2–53.2) | 39.9 (27.4–52.4) | 36.5 (12.4–60.6) | 43.3 (15.3–71.3) | 38.4 (26.2–50.6) | 39.1 (27.9–50.3) | 62.8 (60.4–65.2)a |
I(a) Lymphoid leukemias | 25 (2.9–47.1) | ||||||||
I(b) Acute myeloid leukemias | 48.6 (33.1–64.1) | ||||||||
I(e) Unspecified and other specified leukemias | 36.8 (13.7–59.9) | ||||||||
CNS tumors | III CNS and misc intracranial and intraspinal neoplasms | 17 (2.9–31.1) | 12.4 (0–25.1) | 19.3 (8.1–30.5) | 9.1 (0–21.1) | 19.1 (5.6–32.6) | 15 (5.4–24.6) | 58.5 (55.6–61.4)a | |
III(b) Astrocytomas | 22.9 (5.7–40.1) | ||||||||
III(c) Intracranial and intraspinal embryonal tumors | 9.4 (0–21.6) | ||||||||
Other solid tumors | IV Neuroblastoma and other peripheral nervous cell tumors | 79.7 (71.7–87.7) | 72.5 (61.9–83.1) | 77.8 (70.9–84.7) | 70.1 (52.7–87.5) | 70.6 (58.8–82.4) | 80.1 (72.7–87.5) | 76.8 (70.3–83.3) | 78.6 (76.4–80.8)a |
V Retinoblastoma | 83.9 (63.5–100) | 100 | – | – | – | – | 91.7 (80.5–100) | 95.7 (94.1–97.3)b | |
VI(a) Nephroblastoma and other nonepithelial renal tumors | 62.5 (38.8–86.2) | 87.9 (85.4–90.4)a | |||||||
IX Soft tissue and other extraosseous sarcomas | 46.7 (25.7–67.7) | 59.8 (39.2–80.4) | – | – | 62.5 (38.8–86.2) | 45 (25.6–64.4) | 52.4 (37.5–67.3) | 71.5 (67–76)a | |
IX(a) Rhabdomyosarcomas | 36.3 (12.8–59.8) | ||||||||
IX(b) Fibrosarcomas, peripheral nerve & other fibrous | 76 (57.4–94.6) | ||||||||
IX(d) Other specified soft tissue sarcomas | 31.1 (0–64) | ||||||||
X Germ cell & trophoblastic tumors & neoplasms of gonads | 61.9 (48–75.8) | 71.7 (62.7–80.7) | 68.9 (60.5–77.3) | 66.9 (49.7–84.1) | 51.2 (30.4–72) | 71.3 (63.3–79.3) | 68.3 (60.7–75.9) | 84 (79.9–88.1)a | |
X(a) Intracranial & intraspinal germ cell tumors | 25 (6–44) | ||||||||
X(b) Extracranial & extragonadal germ cell tumors | 63.1 (47.6–78.6) | 80.7 (72.1–89.3) | 75.1 (66.5–83.7) | 73.5 (56.3–90.7) | 51.2 (30.4–72) | 79.2 (71–87.4) | 74.5 (66.7–82.3) | ||
Grand Total | 59.3 (53.4–65.2) | 61.3 (55.6–67) | 60.8 (56.3–65.3) | 57.2 (47.2–67.2) | 57.3 (49.5–65.1) | 61.3 (56.4–66.2) | 60.3 (56.2–64.4) | 72.7 (71.7–73.7)a |
RTh, radiation therapy; Surg, surgery.
P ≤ 0.001.
No statistics were calculated because the group had fewer than 10 patients.
P = 0.043.